Kezdőlap・Részvénylista・Medtronic PLC

Medtronic PLC

Nyitva

SzektorEgészségügy

87.16 1.48

Vétel Eladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

84.96

Maximum

87.16

Fő mutatók
By Trading Economics
Bevétel	130M 1.3B
Értékesítés	789M 9.8B
P/E Szektor átlag	23.239 68.51
Egy részvényre jutó nyereség	1.55
Osztalékhozam	3.33
Profit margin	12.981
Munkavállalók	95,000
EBITDA	147M 2.6B

Ajánlások
By TipRanks
Ajánlások	Vétel
12 hónapos előrejelzés	+11.18% upside

Osztalékok
By Acuity
Osztalékhozam Szektor átlag	3.33% 2.29%
Következő eredményjelentés	2026. szept. 1.
Következő osztalékfizetési dátum	2026. okt. 16.
Következő korábbi osztalék dátum	2026. szept. 25.

Piaci statisztika
By TradingEconomics
Piaci kapitalizáció	14B 109B
Előző nyitás	85.68
Előző zárás	87.16

Hangulat hírek alapján

By Acuity

30%

70%

97 / 340 Rangsor szerint Healthcare

Medtronic PLC Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 6. 20:06 UTC

News

Medtronic PLC announced expanded CE Mark approval for its Sphere-9 Catheter, yet shares are trading lower since Wednesday's close after an earlier uptick.

2026. aug. 5. 19:52 UTC

News

Medtronic PLC shares are lower today amid increased put options volume, reflecting bearish sentiment ahead of the upcoming earnings report on September 1st.

2026. aug. 4. 20:06 UTC

News

Medtronic PLC shares are lower after a jury ruled the company owes $88 million for damages related to Covidien's hernia mesh products.

2026. aug. 3. 23:02 UTC

Medtronic PLC shares are lower in after-market hours, reflecting selling pressure despite trading above its 20-day moving average. No specific news was identified.

2026. júl. 31. 23:46 UTC

Medtronic PLC shares are trading higher in after-market hours, following unusual trading activity and amid rising U.S. Treasury yields and crude oil prices.

2026. júl. 30. 23:31 UTC

Medtronic PLC shares are modestly higher in after-market trading, remaining near the upper end of their one-month range. No specific news was identified.

2026. júl. 29. 21:51 UTC

Medtronic PLC shares are lower in after-market hours, reflecting broader market declines amid renewed inflation and interest rate concerns linked to rising crude oil prices.

2026. júl. 28. 23:26 UTC

Shares of Medtronic PLC are trading higher in after-market hours, maintaining above the 20-day moving average amid a trend of five consecutive daily gains.

2026. júl. 27. 23:46 UTC

Medtronic PLC shares are trading higher in after-market hours, continuing an upward trend and supported by positive sentiment in European markets.

2026. júl. 24. 23:26 UTC

Medtronic PLC's after-market trading remains roughly flat, showing routine performance within a narrow range since Friday's close.

2026. júl. 23. 23:02 UTC

Medtronic PLC shares are trading higher in after-market hours, reaching near the top of their one-month trading range amid broader market stability.

2026. júl. 22. 19:36 UTC

News

Medtronic PLC shares are lower as competition increases from Johnson & Johnson's newly authorized Ottava Surgical Robot for U.S. robotic soft-tissue surgery.

2026. júl. 21. 20:07 UTC

News

Medtronic PLC shares are lower today, impacted by declines in the Health Care Equipment sector. The company recently launched its AI-native surgical platform, Touch Surgery™ Aide.

2026. júl. 20. 22:31 UTC

Medtronic PLC shares are higher in after-market hours, reflecting positive movement in the Health Care Equipment sub-sector. The stock remains above its 20-day moving average.

Társak összehasonlítása

Árváltozás

Medtronic PLC Előrejelzés

Célár

By TipRanks

11.18% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 95.53 USD 11.18%

Magas 118 USD

Alacsony 80 USD

19 Wall Street elemző 12 hónapos célárain alapulva a(z)Medtronic PLC termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

19 ratings

Vétel

Tartás

Eladás

19 Wall Street elemző célárain alapulva a(z)Medtronic PLC termékhez az elmúlt 3 hónapban.

Hangulat

By Acuity

97 / 340 Rangsor szerint Egészségügy

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

Rólunk Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.